Nanohyperthermia softens tumours to improve treatment
The mechanical resistance of tumours and collateral damage of standard treatments often hinder efforts to defeat cancers.
List view / Grid view
News
Mission Therapeutics appoints Colin Goddard as Chairman
Mission Therapeutics have appointed Dr Colin Goddard as non-executive Chairman, effective January 1st 2017.
Diabetic research suggests purslane herb extract mimics insulin
A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.
Can genetic testing determine antimicrobial susceptibility?
Experts at EUCAST have found that genetic methods cannot yet be used to test for susceptibility in a number of important bacterial species.
Jai Patel appointed as Chief Medical Officer of Enterome
Enterome is pleased to announce the appointments of Jai Patel, PhD as Chief Medical Officer and Roger Garceau, MD as non-executive Director.
QGel raises $12 million to grow mini-organs for drug discovery
The biomaterials company QGel has received $12 million to be used to accelerate QGel’s global expansion and broaden the company "organoids" products.
New drug could prevent graft loss in pancreatic islet transplantation
5 December 2016 | By Niamh Louise Marriott, Digital Editor
In a rodent model of islet transplantation, ARA 290 markedly reduced transplantation-induced inflammation, resulting in a marked increase in islet survival...
Enhanced CRISPR allows exploration of disease in every cell type
2 December 2016 | By Niamh Louise Marriott, Digital Editor
These systems will allow researchers worldwide to rapidly and accurately explore the changing role of genes as the cells develop into tissues...
Charles River demonstrates CRISPR/Cas9 genome engineering expertise
2 December 2016 | By Charles Rivers Laboratories
Charles River Laboratories has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology...
Orchard Therapeutics forms strategic alliance with Oxford BioMedica
2 December 2016 | By Niamh Louise Marriott, Digital Editor
Under the terms of the licence agreement, Oxford BioMedica has granted an exclusive intellectual property licence to Orchard for collaboration programmes...
Mouth cancer rates soar over 20 years
1 December 2016 | By Niamh Louise Marriott, Digital Editor
A Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68% in the UK over the last 20 years...
Kymab secures $100 million Series C funding
1 December 2016 | By Niamh Louise Marriott, Digital Editor
The funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies, with clinical development in 2017...
TSRI scientists develop vaccine against fatal prescription opioid overdose
30 November 2016 | By Niamh Louise Marriott, Digital Editor
Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs in animal models...
Genetic differences in amino acid metabolism linked to high risk of diabetes
30 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A study has identified the 5 genetic variants associated with higher levels of the branched-chain amino acids were associated with an increased risk...
German Research Foundation (DFG) gives €87 million to fund 20 new research groups
29 November 2016 | By Niamh Louise Marriott, Digital Editor
The Research Training Groups will receive funding of around €87 million for an initial period of four and a half years...
